2 most recent filings and news items mentioning CELU. Updated every 60 seconds.
OtherJun 30, 2026Neutral
Celularity Inc. executed a $1 million loan agreement with the Philip & Daniele Barach Family Trust carrying a 4.0% interest rate. This private financing event boosts the biotech firm's available liquidity.
View filing at SEC.gov →
LeadershipJun 3, 2026Positive
Celularity Inc appointed Rick Gonzalez as Chief Commercial Officer effective May 29, 2026, to lead global commercialization of cenplacel-L and Lifebank. The appointment supports the company's revenue-generating strategy in the regenerative medicine market, leveraging Gonzalez's 2
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.